Sustained MRD negativity after CAR-T improves outcomes in multiple myeloma healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Gamida Cell Ltd. , a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that its management team will present corporate highlights at the upcoming H.C. Wainwright.
Dublin, Aug. 23, 2023 (GLOBE NEWSWIRE) The "Global Translational Regenerative Medicine Market (2023-2028) by Product Type, Application, and Geography,.
Researchers determined expansion of NK cells with IL-15 and nicotinamide resulted in a high response rate in NHL and multiple myeloma in a small phase 1 trial.